Related Experiment Video
Updated: Jul 29, 2026

Reproductive Techniques for Ovarian Monitoring and Control in Amphibians
Published on: May 12, 2019
Low dose gossypol for male contraception
1Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 200031, China. zpgu@mail.shcnc.ac.cn
Lower gossypol doses (10-12.5 mg daily) effectively induce male infertility by reducing sperm density and motility. This regimen avoids side effects like hypokalemia and irreversibility, with fertility returning after treatment cessation.
Area of Science:
- Reproductive Endocrinology
- Pharmacology
Background:
- Gossypol has shown promise as a male contraceptive.
- Concerns exist regarding its potential side effects, including hypokalemia and irreversibility.
Purpose of the Study:
- To evaluate if reduced gossypol doses can achieve male infertility while mitigating side effects.
- To assess the safety and efficacy of lower gossypol dosages for male contraception.
Main Methods:
- Seventy-seven male volunteers were divided into control, 10 mg gossypol, and 12.5 mg gossypol groups.
- Hormonal levels (testosterone, FSH, LH) and serum potassium were monitored.
- Sperm parameters (density, motility) were assessed pre- and post-treatment.
Main Results:
- Both gossypol groups achieved infertility levels (< 4 million/mL sperm density) within 2 months.
- No significant changes in potassium, testosterone, FSH, or LH were observed.
- No cases of hypokalemia or myoasthenia were reported; fertility returned post-treatment.
Conclusions:
- A loading dose of 10-12.5 mg gossypol daily, followed by a maintenance dose, induces reversible male infertility.
- This regimen effectively avoids hypokalemia and irreversibility, suggesting a safer contraceptive option.
Related Concept Videos
Hormonal Regulation
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Birth Control Methods
Intrauterine Drug Delivery Systems
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are typically...

